Thor Willy Ruud Hansen
- Kernicterus: an international perspectiveThor Willy Ruud Hansen
Section on Neonatology, Department of Pediatrics, Rikshospitalet, University of Oslo, Norway
Semin Neonatol 7:103-9. 2002..Further studies regarding bilirubin toxicity and neonatal jaundice are needed, both in the basic science as well as in the clinical arena...
- Extreme neonatal jaundice: how frequent is it?Thor Willy Ruud Hansen
Neonatal Intensive Care Unit, Division of Paediatrics, Rikshospitalet University Hospital and Faculty of Medicine, Faculty Division Rikshospitalet, University of Oslo, Norway
Acta Paediatr 97:1002-3. 2008
- Recent advances in the pharmacotherapy for hyperbilirubinaemia in the neonateThor Willy Ruud Hansen
Department of Pediatrics, Rikshospitalet, NO 0027, Oslo, Norway
Expert Opin Pharmacother 4:1939-48. 2003..Both the displacement of bilirubin from its albumin binding and interference with the function of phosphoglycoprotein in the blood-brain barrier are documented mechanisms in this respect...
- Compatibility of drug infusions in the NICUBetty Kalikstad
Institute of Clinical Medicine, University of Oslo, Norway
Arch Dis Child 95:745-8. 2010..Our aim was to study the compatibility of co-infusions for a selected group of drugs and nutrition solutions as part of our quality assurance programme in the neonatal intensive care unit...
- Diagnosis of congenital hip dysplasia in the newbornPer Haavwardsholm Finne
Department of Pediatrics, Rikshospitalet HC, University of Oslo, Oslo, Norway
Acta Orthop 79:313-20. 2008..Thus, we evaluated the real-life performance of a screening program for detection of congenital hip dysplasia in newborn infants...
- Novel mutations in the gene encoding ATP binding cassette protein member A3 (ABCA3) resulting in fatal neonatal lung diseaseOla D Saugstad
Department of Pediatric Research, Rikshospitalet Radiumhospitalet Health Trust, University of Oslo, Oslo, Norway
Acta Paediatr 96:185-90. 2007..To investigate whether intractable respiratory distress syndrome in three Norwegian term infants was due to mutations in the ABCA3 gene...
- Recovery after short-term bilirubin exposure in human NT2-N neuronsErik Hankø
Department of Pediatric Research, Rikshospitalet Radiumhospitalet Medical Center, University of Oslo, Oslo, Norway
Brain Res 1103:56-64. 2006..We conclude that UCB-mediated effects may be reversible in this model. Blockade of excitotoxic mechanisms, but not caspase activity may prevent delayed cell death...
- Nils Rosén von Rosenstein and neonatal jaundice in the 18th centuryThor Willy Ruud Hansen
Department of Paediatrics, Rikshospitalet Radiumhospitalet University Hospital, University of Oslo, Oslo, Norway
Acta Paediatr 94:1834-6. 2005..His series of lectures on children's diseases and their treatment was published in 1764 under the title Underrättelser om Barn-Sjukdomar och Deras Bote-Medel...
- Changes in the utilization of diagnostic codes in neonatology following the introduction of activity-based financingThor Willy Ruud Hansen
Department of Pediatrics, Rikshospitalet University Hospital, University of Oslo, Barneklinikken, Rikshospitalet, NO 0027 Oslo, Norway
Health Policy 74:218-23. 2005..On the other hand, activity-based financing may result in increased attention to the diagnostic process, leading to increased use of secondary diagnoses and thus more complete diagnostic coding...
- Deaths in a neonatal intensive care unit: a 10-year perspectiveCathrine Monrad Hagen
Section on Neonatology, Department of Pediatrics, Rikshospitalet, University of Oslo, Oslo, Norway
Pediatr Crit Care Med 5:463-8. 2004..To examine changes in the characteristics and management of infants dying in a regional neonatal intensive care unit in 1987-1988 vs. 1997-1998...
- Mechanisms of bilirubin toxicity: clinical implicationsThor Willy Ruud Hansen
Section on Neonatology, Department of Pediatrics, Rikshospitalet, University of Oslo, NO 0027 Oslo, Norway
Clin Perinatol 29:765-78, viii. 2002..Neurological symptoms in a jaundiced infant require extreme vigilance, and, in most cases, immediate intervention...
- [Treatment of neonatal jaundice]Thor Willy Ruud Hansen
Nyfødtseksjonen, Barneklinikken, Rikshospitalet, 0027 Oslo
Tidsskr Nor Laegeforen 125:594-8. 2005..Therapy is given because pronounced jaundice carries a risk for brain damage (kernicterus). Intervention limits for therapy continue to be debated, as the scientific basis suffers from obvious weaknesses...
- Management of jaundice and prevention of severe neonatal hyperbilirubinemia in infants >or=35 weeks gestationVinod K Bhutani
School of Medicine at Stanford University, Stanford, CA, USA
Neonatology 94:63-7. 2008..Translational research is needed to better understand the mechanisms of bilirubin neurotoxicity and potential therapeutic interventions...
- [Screening for congenital hearing loss--a pilot project]Runa Helen Kaldestad
Nyfødtseksjonen Barneklinikken Rikshospitalet 0027 Oslo
Tidsskr Nor Laegeforen 122:2190-3. 2002..Until recently in Norway, congenital hearing loss has on average been diagnosed at 2.8 years of age. Delayed diagnosis is associated with loss of valuable opportunities for auditory habilitation and speech development...
- [Fiberoptic phototherapy for neonatal icterus--comments to a Cochrane report]Thor Willy Ruud Hansen
Nyfødtseksjonen Barneklinikken Rikshospitalet 0027 Oslo
Tidsskr Nor Laegeforen 122:45-7. 2002..Fiberoptic phototherapy has not been shown to interfere less with parent-infant bonding than conventional phototherapy. There is still a great need for more research on phototherapy for neonatal jaundice...